Luo Ying sold GYRE

May 6, 2026 · Form 4 insider transaction

Luo Ying sold 10,136 shares of Gyre Therapeutics, Inc. at $8.04 per share, a transaction worth $81.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
10,136
Price
$8.04
Total value
$81.5K
InsiderLuo Ying
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 6, 2026
Filing dateMay 7, 2026
Shares owned after2,565,226
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.; The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.071. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR